| dc.contributor.author | Yorulmaz, Eda | |
| dc.contributor.author | Baki, Adile Merve | |
| dc.contributor.author | Dogru-Abbasoglu, Semra | |
| dc.contributor.author | Vural, Pervin | |
| dc.contributor.author | Okan, Gokhan | |
| dc.date.accessioned | 2021-03-04T11:15:28Z | |
| dc.date.available | 2021-03-04T11:15:28Z | |
| dc.date.issued | 2016 | |
| dc.identifier.citation | Okan G., Baki A. M. , Yorulmaz E., Dogru-Abbasoglu S., Vural P., "Serum Visfatin, Fetuin-A, and Pentraxin 3 Levels in Patients With Psoriasis and Their Relation to Disease Severity", JOURNAL OF CLINICAL LABORATORY ANALYSIS, cilt.30, sa.4, ss.284-289, 2016 | |
| dc.identifier.issn | 0887-8013 | |
| dc.identifier.other | av_716f341e-2827-431d-8d64-9bb2d919ae17 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/78131 | |
| dc.identifier.uri | https://doi.org/10.1002/jcla.21850 | |
| dc.description.abstract | BackgroundPsoriasis is a chronic immune-mediated inflammatory skin disease associated with increase of some pro-inflammatory mediators. We wanted to investigate whether there is a relationship between psoriasis and visfatin, fetuin-A and pentraxin 3 (PTX3)pro-inflammatory mediators implicated in the development of insulin resistance (IR), metabolic syndrome, and atherosclerosis. | |
| dc.language.iso | eng | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | TIBBİ LABORATUVAR TEKNOLOJİSİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Tıp | |
| dc.title | Serum Visfatin, Fetuin-A, and Pentraxin 3 Levels in Patients With Psoriasis and Their Relation to Disease Severity | |
| dc.type | Makale | |
| dc.relation.journal | JOURNAL OF CLINICAL LABORATORY ANALYSIS | |
| dc.contributor.department | Altınbaş Üniversitesi , , | |
| dc.identifier.volume | 30 | |
| dc.identifier.issue | 4 | |
| dc.identifier.startpage | 284 | |
| dc.identifier.endpage | 289 | |
| dc.contributor.firstauthorID | 95451 | |
